HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A one-year carcinogenicity study with 2,6-dichlorobenzonitrile (Dichlobenil) in male Swiss mice: preliminary note.

Abstract
2,6-Dichlorobenzonitrile (Dichlobenil) is the active principle of a commercial herbicide that was previously shown to be carcinogenic for animals. Dichlobenil was administered to male Swiss albino mice in order to assess the possible oncogenic properties of the active principle alone. The substance at 2 ppm concentration was injected (0.0005 mg/injection) either by subcutaneous or intraperitoneal route to 2 randomized groups of 30 animals each every third day for 13 times. Dichlobenil induced a significant increase of malignant tumors (lymphoma, mesothelioma, hepatocellular carcinoma, and pulmonary alveologenic carcinoma) with respect to the controls (p less than 0.01 in both treated groups). As for tumor histotypes, only lymphoma incidence was significantly increased in the intraperitoneally treated animals (p less than 0.05). Dichlobenil can be suspected of being a possible carcinogen in Swiss mice but the mechanism of its action is not precisely known.
AuthorsA Donna, P G Betta, F Robutti, D Bellingeri
JournalCancer detection and prevention (Cancer Detect Prev) Vol. 15 Issue 1 Pg. 41-4 ( 1991) ISSN: 0361-090X [Print] England
PMID2044073 (Publication Type: Journal Article)
Chemical References
  • Benzamides
  • Nitriles
  • dichlobanil
Topics
  • Animals
  • Benzamides (toxicity)
  • Carcinogenicity Tests
  • Carcinoma (chemically induced)
  • Leukemia, Lymphocytic, Chronic, B-Cell (chemically induced, pathology)
  • Liver Neoplasms (chemically induced)
  • Longitudinal Studies
  • Lung Neoplasms (chemically induced)
  • Lymphoma, Large B-Cell, Diffuse (chemically induced, pathology)
  • Male
  • Mesothelioma (chemically induced)
  • Mice
  • Neoplasms, Experimental (chemically induced, pathology)
  • Nitriles
  • Random Allocation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: